T. Rowe Price Funds SICAV - Global Focused Growth Equity Fund A EURRegister to Unlock Ratings |
Performance History | 30/09/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 44.6 | 10.3 | -21.1 | 18.3 | 12.0 | |
+/-Cat | 20.9 | -4.3 | -3.0 | 2.3 | 2.6 | |
+/-B’mrk | - | -7.8 | -2.1 | -4.0 | -2.4 | |
Category: Global Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar Gbl Growth TME ... |
Key Stats | ||
NAV 30/10/2024 | EUR 30.92 | |
Day Change | -0.78% | |
Morningstar Category™ | Global Large-Cap Growth Equity | |
ISIN | LU1438969351 | |
Fund Size (Mil) 30/10/2024 | USD 4119.34 | |
Share Class Size (Mil) 30/10/2024 | EUR 176.67 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 24/10/2024 | 1.72% |
Investment Objective: T. Rowe Price Funds SICAV - Global Focused Growth Equity Fund A EUR |
To increase the value of its shares, over the long term, through growth in the value of its investments. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
David Eiswert 01/10/2012 | ||
Nabil Hanano 01/01/2020 | ||
Inception Date 30/06/2016 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI NR USD | Morningstar Gbl Growth TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for T. Rowe Price Funds SICAV - Global Focused Growth Equity Fund A EUR | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Eli Lilly and Co | Healthcare | 5.89 |
Microsoft Corp | Technology | 4.08 |
Apple Inc | Technology | 4.02 |
Advanced Micro Devices Inc | Technology | 3.23 |
ConocoPhillips | Energy | 2.91 |
Increase Decrease New since last portfolio | ||
T. Rowe Price Funds SICAV - Global Focused Growth Equity Fund A EUR |